PTC Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update

Go back to PTC Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update
PTC THERAPEUTICS (NASDAQ: PTCT) Delayed: 67.96 +0.37 (0.55%)
Previous Close $67.59    52 Week High $35.40 
Open $68.84    52 Week Low $4.03 
Day High $68.84    P/E 7.23 
Day Low $67.22    EPS $9.40 
Volume 735,444